Semua Kategori
| Product Name | Deskripsi | Action |
|---|---|---|
| Denosumab, Prolia, RANK ligand, AMG 162, RANKL-targeted biologic, IgG2 monoclonal antibody manusia, CAS No. 615258-40-7 | Trade Name : Prolia Target : RANK ligand Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 3360(First three quarters) All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with ... |
|
| Infliximab,Remicade,CA2,TA-650,Anti-TNF biologic / TNF inhibitor,Chimeric monoclonal antibody,Autoimmune therapeutic / Rheumatology biologic,Infusi intravena,CAS No. 170277-31-3 | Trade Name : Remicade Target : N/A Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 4100 All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Pembrolizumab,Keytruda,PD-1,Lambrolizumab,MK-3475,SCH 900475,Antibodi Monoklonal,CAS No.1374853-91-4 | Trade Name : Keytruda Target : PD-1 Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : 30990 All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Bevacizumab,Avastin,VEGF,Anti-VEGF monoklonal antibodi,Anti-VEGF monoklonal antibodi,Humanized IgG1 antibodi,Oncology biologic / Antiangiogenic therapy,CAS No. 216974-75-3 | Trade Name : Avastin Target : VEGF Molecular Type : Monoclonal Antibody Sales in 2025 (Millions of USD) : N/A All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Vedolizumab ,Entyvio ,MLN0002 ,Biologik anti-integrin ,Antibodi monoklonal IgG1 yang dihumanisasi ,Terapi IBD / Biologik kolitis ulserativa / Biologik penyakit Crohn ,No. CAS 943609-66-3 | Trade Name : Entyvio Target : N/A Molecular Type : N/A Sales in 2025 (Millions of USD) : N/A All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for this item, kindly get in touch with us. |
|
| Imiglucerase,Cerezyme,rGCR,GBA (β- glucocerebrosid ase),Glycoprotein (Ini adalah protein yang mengandung 497 asam amino, diproduksi dengan menggunakan teknologi DNA rekombinan), CAS No. 154248-97-2 | Trade Name : Cerezyme® Target : GBA (β- glucocerebrosid ase) Molecular Type : Glycoprotein (This is a protein containing 497 amino acids, produced using recombinant DNA technology) Sales in 2025 (Millions of USD) : 1105(estimate) All detailed product information shall be subject to the issued final ... |
|
| Luspatercept-aamt | Trade Name : Reblozyl Target : Transforming growth factor-β (TGF- β)superfamily ligands Molecular Type : Recombinant Fusion Protein Sales in 2025 (Millions of USD) : 2000 All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentation for ... |
|
| Relatlimab,Opdualag,BMS-986016,Anti-LAG-3 inhibitor titik pemeriksaan kekebalan tubuh,Lymphocyte-activation gene- 3 (LAG-3),Humanized Immunoglobulin G4 (IgG4) Monoclonal Antibodi,CAS No. 1673516-98-7 | Trade Name : Opdualag Target : Lymphocyte- activation gene- 3 (LAG-3) Molecular Type : Humanized Immunoglobulin G4 (IgG4) Monoclonal Antibody Sales in 2025 (Millions of USD) : 1358 All detailed product information shall be subject to the issued final COA. Should you need further in-depth documentati... |
